News | December 27, 2025
Zeon Corporation to acquire Ushio’s microfluidics biz
Ushio, a leader in advanced optical technologies, brings a strong track record and proprietary Photobonding technology
Ushio, a leader in advanced optical technologies, brings a strong track record and proprietary Photobonding technology
BaseLaunch has supported 27 biotech companies across multiple modalities and indications
The funding will support the pivotal Phase 3 clinical trial of neridronate in CRPS-1
The Signals Xynthetica solution brings AI-driven in-silico generation, predictive modeling, and experimental validation into a single, governed environment
The ChemiSphere app exemplifies how M-Trust technology transforms workflows into seamless digital experiences
Ryght AI tackles these hurdles with its AI Site Twin platform
The agreement pairs Croda’s global footprint and “smart science” approach with Amino’s precision manufacturing capabilities
Freenome expects the combined company to receive approximately $330 million in proceeds at closing
Alport Syndrome is caused by genetic mutations affecting type IV collagen in the kidneys, ears, and eyes
NAEH can cause heavy or abnormal bleeding and, if left untreated, may progress to uterine cancer
Subscribe To Our Newsletter & Stay Updated
